BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 29954442)

  • 1. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
    Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z
    J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
    Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
    BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
    Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
    J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
    Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
    Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
    Wong CM; Wei L; Au SL; Fan DN; Zhou Y; Tsang FH; Law CT; Lee JM; He X; Shi J; Wong CC; Ng IO
    Oncotarget; 2015 May; 6(15):13658-70. PubMed ID: 25909223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
    Qin CD; Ma DN; Zhang SZ; Zhang N; Ren ZG; Zhu XD; Jia QA; Chai ZT; Wang CH; Sun HC; Tang ZY
    Cell Death Dis; 2018 May; 9(5):486. PubMed ID: 29706627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Zhong Y; Huang H; Chen M; Huang J; Wu Q; Yan GR; Chen D
    Oncotarget; 2017 Jul; 8(27):44082-44095. PubMed ID: 28489585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
    Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
    Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
    Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
    Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.
    Lin ZH; Wang L; Zhang JB; Liu Y; Li XQ; Guo L; Zhang B; Zhu WW; Ye QH
    Int J Oncol; 2014 Aug; 45(2):629-40. PubMed ID: 24859810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
    Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling.
    Cheng IK; Tsang BC; Lai KP; Ching AK; Chan AW; To KF; Lai PB; Wong N
    J Pathol; 2012 Dec; 228(4):575-85. PubMed ID: 22847784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.